21st century bloodletting reduces cardiovascular risk

It seems that while the practice of bloodletting throughout history had little or no effect on most diseases, and the practice was abandoned in the 19th century, new research published in BioMed Central's open access journal BMC Medicine demonstrates that blood donation has real benefits for obese people with metabolic syndrome. Two sessions of bloodletting were enough to improve blood pressure and markers of cardiovascular disease.

Metabolic syndrome is the name given to a host of difficulties affecting people who are obese. This includes , , dyslipidemia and hypertension and leads to an increased risk of diabetes and cardiovascular disease. Since it is known that accumulation of iron in the body is also associated with hypertension and diabetes researchers from Berlin and University Duisburg-Essen randomly assigned patients with into two groups, those undergoing iron reduction by phlebotomy and controls.

The iron-reduction patients had 300ml of blood removed at the start of the trial and between 250 and 500ml removed four weeks later. Six weeks later, allowing plenty of time for blood volume to be replaced, the patients who gave blood had a significant reduction in systolic blood pressure (from 148 mmHg to 130 mmHg) as well as reduction in and heart rate, and an improvement in (LDL/HDL ratio).

Prof Andreas Michalsen from the Charité-University Medical Centre, Berlin, who led this research explained, "Consecutive reduction in iron stores was able to improve markers of cardiovascular risk and glycemic control. Consequently blood donation may prevent not just diabetes but also cardiovascular disease for the obese. Obviously this treatment will not be suitable for people with anaemia however for those eligible for treatment blood donation may prevent escalation of their condition."

More information: Effects of phlebotomy-induced reduction of body iron stores on metabolic syndrome: Results from a randomized clinical trial
Khosrow S Houschyar, Rainer Lüdtke, Gustav J Dobos, Ulrich Kalus, Martina Bröcker-Preuss, Thomas Rampp, Benno Brinkhaus and Andreas Michalsen, BMC Medicine (in press)

Related Stories

Recommended for you

1950s drug is future heart treatment

date 8 hours ago

Oxford University researchers have found a promising future treatment for heart disease, going back to a drug first developed in 1950.

Time is muscle in acute heart failure

date 17 hours ago

Urgent diagnosis and treatment in acute heart failure has been emphasised for the first time in joint recommendations published today in European Heart Journal.

Common mutation linked to heart disease

date May 20, 2015

A common mutation in a gene that regulates cholesterol levels may raise the risk of heart disease in carriers, according to a new UConn Health study.

User comments

Adjust slider to filter visible comments by rank

Display comments: newest first

cyberCMDR
May 30, 2012
I usually feel better after donating blood. Perhaps this is why.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.